• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Benzenamine, 3,5-difluoro-N-methyl-2-nitro- (CAS No. 872367-64-1): A Comprehensive Overview

Benzenamine, 3,5-difluoro-N-methyl-2-nitro-, identified by its Chemical Abstracts Service (CAS) number 872367-64-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of nitroaromatic amines, characterized by its nitro and fluoro substituents on a benzene ring, along with a methyl group at the N position. The unique structural features of this molecule make it a valuable intermediate in the synthesis of various pharmacologically active agents.

The 3,5-difluoro substitution pattern on the benzene ring imparts distinct electronic and steric properties to the molecule, influencing its reactivity and potential biological activity. The presence of a nitro group at the 2-position further enhances its utility in medicinal chemistry due to the electron-withdrawing nature of the nitro moiety. This combination of substituents makes Benzenamine, 3,5-difluoro-N-methyl-2-nitro- a versatile building block for designing novel therapeutic compounds.

In recent years, there has been a surge in research focused on developing new analogs of nitroaromatic amines due to their broad spectrum of biological activities. These activities include antimicrobial, antitumor, and anti-inflammatory properties. The fluoro substituents in particular have been shown to improve metabolic stability and bioavailability of drug candidates, making them highly desirable in drug design.

The N-methyl group in Benzenamine, 3,5-difluoro-N-methyl-2-nitro- plays a crucial role in modulating the pharmacokinetic profile of derived compounds. Methylation at the nitrogen atom can enhance lipophilicity and binding affinity to biological targets, thereby improving drug efficacy. This compound has been extensively studied as a precursor for synthesizing kinase inhibitors, which are critical in targeted cancer therapies.

One of the most compelling aspects of Benzenamine, 3,5-difluoro-N-methyl-2-nitro- is its potential application in developing next-generation antibiotics. The structural motifs present in this molecule mimic natural products that exhibit potent antimicrobial activity. Researchers have leveraged its scaffold to create derivatives with enhanced resistance against pathogenic bacteria. The nitro and fluoro groups contribute to its ability to disrupt bacterial cell wall synthesis and DNA replication, offering a promising strategy against multidrug-resistant strains.

The synthesis of Benzenamine, 3,5-difluoro-N-methyl-2-nitro- involves multi-step organic transformations that highlight the ingenuity of modern synthetic chemistry. Key steps include nitration of fluorobenzene derivatives followed by selective methylation and functional group interconversion. Advanced catalytic methods have been employed to improve yields and reduce environmental impact. These synthetic strategies are not only efficient but also align with green chemistry principles by minimizing waste and hazardous byproducts.

The pharmacological evaluation of derivatives derived from Benzenamine, 3,5-difluoro-N-methyl-2-nitro- has revealed intriguing biological profiles. Preclinical studies indicate that certain analogs exhibit potent inhibitory effects on enzymes involved in cancer progression. The fluoro-substituted nitroaromatic amine derivatives have shown particular promise in targeting tyrosine kinases, which are overexpressed in many solid tumors. This has spurred interest among oncologists for further development into clinical candidates.

In addition to its oncology applications, this compound has shown potential in treating inflammatory diseases. The nitro group can be reduced to an amine under specific conditions, generating reactive intermediates that can modulate inflammatory pathways. Such derivatives are being explored as novel anti-inflammatory agents with mechanisms distinct from traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

The role of computational chemistry in optimizing Benzenamine, 3,5-difluoro-N-methyl-2-nitro--based drug candidates cannot be overstated. Molecular modeling techniques have been instrumental in predicting binding affinities and identifying lead compounds with improved pharmacokinetic profiles. High-throughput virtual screening has accelerated the discovery process by allowing rapid evaluation of thousands of derivatives without experimental synthesis.

The future prospects forBenzenamine, 3,5-difluoro-N-methyl-2-nitro--based therapeutics are bright given the ongoing advancements in synthetic methodologies and drug discovery technologies. Continued exploration into its derivatives promises to yield novel treatments for a wide range of diseases. As research progresses, it is likely that this compound will find even broader applications beyond oncology and inflammation management.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)